Precision medicine and phenotyping help tailor treatments to individual patient profiles.

Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- ...

Airway cells normally move the mucus they ... suggest that the intelectin-1 protein is involved in mucus obstruction among ...

Spirair, Inc., an early-stage company developing minimally invasive solutions to help ENTs improve patient care, today ...

For COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher ...

The American College of Chest Physicians published a clinical practice guideline on management of central airway obstruction. Panelists emphasize the need for a multidisciplinary, patient-centric ...

When total airway resistance is elevated to a clinically ... representing fixed obstruction in patients with chronic lung disease. The relative contribution of these two components in our patients ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

a novel oral drug that targets the neuromuscular root cause of airway obstruction in sleep apnea and holds promise for transforming care for a broad range of patients.” Full results from the ...

Three-Year Study Confirms Long-Term Efficacy of VivAer® Treatment, Demonstrating Sustained Symptom Relief, Improved Sleep, Enhanced Quality of Life, and Reduced Medication Burden MOUNTAIN VIEW ...

Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea.